NUCLEOLIN and cancer: Therefore, by establishing nucleolin’s role in EH and EC and comparing effects between women of different BMI on disease progression, mortality, and recurrence, NCL may be studied as a potential target for both cancer prevention and anti-cancer therapies in this particular at-risk EH patient group.